DelphX Announces Non-Brokered Unit Private Placement

Rhea-AI Summary

DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 1,250,000 units at C$0.04 per unit for gross proceeds of C$50,000. Each unit includes one common share and one warrant; each warrant is exercisable for one common share at $0.06 for two years from issuance. Completion is subject to TSX Venture Exchange approval and issued securities will be subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.

Positive

• Gross proceeds of C$50,000 to fund working capital
• Warrants provide optional future capital at $0.06 within two years

Negative

• Issuance of 1,250,000 units creates immediate share dilution
• Warrants could issue an additional 1,250,000 shares if exercised

Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it intends to proceed with a non-brokered private placement ("the Offering") of 1,250,000 units (the "Units") at a subscription price of C$0.04 per Unit, for gross proceeds of C$50,000. Each Unit will consist of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant will entitle the holder to purchase one Common Share at a price of $0.06, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com.

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278688

FAQ

What is the size and price of the DelphX (DPXCF) private placement announced on December 19, 2025?

DelphX is offering 1,250,000 units at C$0.04 per unit for gross proceeds of C$50,000.

What does each DelphX unit include and what are the warrant terms in the December 19, 2025 offering?

Each unit includes one common share and one warrant; each warrant is exercisable for one share at $0.06 for two years from issuance.

How will DelphX (DPXCF) use the proceeds from the C$50,000 private placement?

DelphX intends to use the net proceeds for working capital and corporate overhead.

Is the DelphX private placement subject to regulatory approval and resale restrictions?

Yes; completion is subject to TSX Venture Exchange approval and securities carry a four-month plus one day hold period.

How many additional shares could be created if all DelphX warrants from the offering are exercised?

If all warrants are exercised, up to 1,250,000 additional common shares could be issued at $0.06 each.